ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
前收盘价
US$17.83
+US$0.13 · +0.73%
盘前
US$17.20
−US$0.63 · -3.53%
10月15日 4:01 ET
盘中时间采用ET。市场数据可能有所延迟。
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
日内区间
当前US$17.83
52周区间
当前US$17.83
盘中时间采用ET。市场数据可能有所延迟。
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
日内区间
当前US$17.83
52周区间
当前US$17.83
报告持有此股票敞口的交易所交易基金。
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFTMED
T. Rowe Price Biotech ETFTDNA
T. Rowe Price Small Cap ETFTSEEAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
